• 1.

    Hendrick MJ, Goldschmidt MH. Do injection site reactions induce fibrosarcomas in cats? J Am Vet Med Assoc 1991;199:968.

  • 2.

    McEntee MC, Page RL. Feline vaccine-associated sarcomas. J Vet Intern Med 2001;15:176182.

  • 3.

    McNiel EA. Vaccine-associated sarcomas in cats: a unique cancer model. Clin Orthop 2001;382:2127.

  • 4.

    Morrison WB, Starr RM. Vaccine-Associated Feline Sarcoma Task Force. Vaccine-associated feline sarcomas. J Am Vet Med Assoc 2001;218:697702.

    • Search Google Scholar
    • Export Citation
  • 5.

    Hendrick MJ, Brooks JJ. Postvaccinal sarcomas in the cat: histology and immunohistochemistry. Vet Pathol 1994;31:12261229.

  • 6.

    Hershey AE, Sorenmo KU, Hendrick MJ, et al. Prognosis for presumed feline vaccine-associated sarcoma after excision: 61 cases (1986–1996). J Am Vet Med Assoc 2000;216:5861.

    • Search Google Scholar
    • Export Citation
  • 7.

    Nieto A, nchez MA, Martínez E, et al. Immunohistochemical expression of p53, fibroblast growth factor-b, and transforming growth factor-alpha in feline vaccine-associated sarcomas. Vet Pathol 2003;40:651658.

    • Search Google Scholar
    • Export Citation
  • 8.

    Hershey AE, Dubielzig RR, Padilla ML, et al. Aberrant p53 expression in feline vaccine-associated sarcomas and correlation with prognosis. Vet Pathol 2005;42:805811.

    • Search Google Scholar
    • Export Citation
  • 9.

    Kobayashi T, Hauck ML, Dodge R, et al. Preoperative radiotherapy for vaccine associated sarcoma in 92 cats. Vet Radiol Ultrasound 2002;43:473479.

    • Search Google Scholar
    • Export Citation
  • 10.

    Coindre JM. Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med 2006;130:14481453.

  • 11.

    Kuntz CA, Dernell WS, Powers BE, et al. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986–1996). J Am Vet Med Assoc 1997;211:11471151.

    • Search Google Scholar
    • Export Citation
  • 12.

    Nguyen BB, Bonichon F, de Mascarel I, et al. Histopathologic grading in spindle cell soft tissue sarcomas. Cancer 1988;61:23052309.

  • 13.

    Couto SS, Griffey SM, Duarte PC, et al. Feline vaccine-associated fibrosarcoma: morphologic distinctions. Vet Pathol 2002;39:3341.

  • 14.

    Cronin K, Page RL, Spodnick G, et al. Radiation therapy and surgery for fibrosarcoma in 33 cats. Vet Radiol Ultrasound 1998;39:5156.

  • 15.

    Cohen M, Wright JC, Brawner WR, et al. Use of surgery and electron beam irradiation, with or without chemotherapy, for treatment of vaccine-associated sarcomas in cats: 78 cases (1996–2000). J Am Vet Med Assoc 2001;219:15821589.

    • Search Google Scholar
    • Export Citation
  • 16.

    Hendrick MJ, Mahaffey EA, Moore FS, et al. Histological classification of mesenchymal tumors of skin and soft tissues of domestic animals. 2nd series. Vol II. Washington, DC: Armed Forces Institute of Pathology, 1998.

    • Search Google Scholar
    • Export Citation
  • 17.

    Liptak JM, Forrest LJ. Soft tissue sarcomas. In: Withrow SJ, Vail DM, eds. Withrow & MacEwen's small animal clinical oncology. 4th ed. Philadelphia: WB Saunders Co, 2007;442449.

    • Search Google Scholar
    • Export Citation
  • 18.

    Hauck M. Feline injection site sarcomas. Vet Clin North Am Small Anim Pract 2003;33:553557.

  • 19.

    Novosad CA. Principles of treatment for vaccine-associated sarcomas. Clin Tech Small Anim Pract 2003;18:115117.

  • 20.

    Ogilvie GK. Recent advances in the treatment of vaccine-associated sarcomas. Vet Clin North Am Small Anim Pract 2001;31:525533.

  • 21.

    Poirier VJ, Thamm DH, Kurzman ID, et al. Liposome-encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccineassociated sarcoma in cats. J Vet Intern Med 2002;16:726731.

    • Search Google Scholar
    • Export Citation
  • 22.

    Rassnick KM, Rodriguez CO, Khanna C, et al. Results of a phase II clinical trial on the use of ifosfamide for treatment of cats with vaccine-associated sarcomas. Am J Vet Res 2006;67:517523.

    • Search Google Scholar
    • Export Citation
  • 23.

    Bregazzi VS, LaRue SM, McNiel E, et al. Treatment with a combination of doxorubicin, surgery, and radiation versus surgery and radiation alone for cats with vaccine-associated sarcomas: 25 cases (1995–2000). J Am Vet Med Assoc 2001;218:547550.

    • Search Google Scholar
    • Export Citation
  • 24.

    Dernell WS, Withrow SJ, Kuntz CA, et al. Principles of treatment for soft tissue sarcoma. Clin Tech Small Anim Pract 1998;13:5964.

  • 25.

    Stotter AT, A'Hern RP, Fisher C, et al. The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival. Cancer 1990;65:11191129.

    • Search Google Scholar
    • Export Citation
  • 26.

    Dickinson IC, Whitwell DJ, Battistuta D, et al. Surgical margin and its influence on survival in soft tissue sarcoma. ANZ J Surg 2006;76:104109.

    • Search Google Scholar
    • Export Citation
  • 27.

    Trovik CS, Bauer HC, Alvegård TA, et al. Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer 2000;36:710716.

    • Search Google Scholar
    • Export Citation
  • 28.

    Stojadinovic A, Leung DH, Hoos A, et al. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg 2002;235:424434.

    • Search Google Scholar
    • Export Citation
  • 29.

    Zagars GK, Ballo MT, Pisters PW, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 225 patients. Cancer 2003;97:25302543.

    • Search Google Scholar
    • Export Citation

Advertisement

Analysis of prognostic factors associated with injection-site sarcomas in cats: 57 cases (2001–2007)

View More View Less
  • 1 Clinica Veterinaria Nerviano, via Lampugnani 3, 20014 Nerviano (MI), Italy.
  • | 2 Clinica Veterinaria L'Arca, Vico Cacciottoli 46/47, 80129 Naples, Italy.
  • | 3 BiEsseA Laboratory of Veterinary Analysis, Via Amedeo D'Aosta 7, 20129, Milano, Italy.
  • | 4 Clinica Veterinaria Nerviano, via Lampugnani 3, 20014 Nerviano (MI), Italy.
  • | 5 Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zürich, 8057 Zürich, Switzerland.

Abstract

Objective—To identify prognostic factors in cats with injection-site sarcomas (ISSs).

Design—Retrospective case series.

Animals—57 cats with ISSs.

Procedures—Medical records of cats were reviewed with regard to sex, age, anatomic site of tumor, tumor size, histologic grade, excision of a primary tumor versus excision of a recurrent ISS, use of excision alone versus excision plus adjuvant therapy, local tumor recurrence, and development of distant metastasis to predict overall survival time (ie, time from tumor excision to death).

Results—In univariate analyses, local recurrence and development of distant metastasis were significantly associated with survival time in cats. On multivariate analysis, development of distant metastasis remained a significant prognostic factor. Histologic grade was associated with distant metastasis, with cats having grade 3 tumors being significantly more likely to develop metastasis than cats with grade 1 and 2 tumors. Factors associated with local recurrence of ISSs were not identified.

Conclusions and Clinical Relevance—The development of distant metastasis, which may occur later during the course of the disease, was identified as a prognostic factor for overall survival time in cats with ISSs. In addition, cats with histologic grade 3 ISSs should be considered for further interventional studies with chemotherapy to prevent the high rate of distant metastasis.

Abstract

Objective—To identify prognostic factors in cats with injection-site sarcomas (ISSs).

Design—Retrospective case series.

Animals—57 cats with ISSs.

Procedures—Medical records of cats were reviewed with regard to sex, age, anatomic site of tumor, tumor size, histologic grade, excision of a primary tumor versus excision of a recurrent ISS, use of excision alone versus excision plus adjuvant therapy, local tumor recurrence, and development of distant metastasis to predict overall survival time (ie, time from tumor excision to death).

Results—In univariate analyses, local recurrence and development of distant metastasis were significantly associated with survival time in cats. On multivariate analysis, development of distant metastasis remained a significant prognostic factor. Histologic grade was associated with distant metastasis, with cats having grade 3 tumors being significantly more likely to develop metastasis than cats with grade 1 and 2 tumors. Factors associated with local recurrence of ISSs were not identified.

Conclusions and Clinical Relevance—The development of distant metastasis, which may occur later during the course of the disease, was identified as a prognostic factor for overall survival time in cats with ISSs. In addition, cats with histologic grade 3 ISSs should be considered for further interventional studies with chemotherapy to prevent the high rate of distant metastasis.

Contributor Notes

Address correspondence to Dr. Marconato.